Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Liquid Biopsy Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


Liquid Biopsy Market Introduction

The global liquid biopsy market has gained significant attention and witnessed remarkable growth in recent years, driven by advancements in cancer diagnostics and personalized medicine. Liquid biopsy refers to the non-invasive detection and analysis of biomarkers, such as circulating tumor DNA (ctDNA) or circulating tumor cells (CTCs), in biofluids like blood or urine. It offers a promising alternative to traditional tissue biopsies, enabling early cancer detection, monitoring treatment response, and identifying potential drug resistance. This report provides a comprehensive analysis of the liquid biopsy market, including market share insights, size estimations, and a detailed market analysis.

Liquid Biopsy Market Overview

The future of the global liquid biopsy market looks promising with opportunities in reference laboratories, hospitals and physician laboratories, and academic and research centers.The global liquid biopsy market is expected to reach an estimated $9.3 billion by 2030 with a CAGR of 13.3% from 2024 to 2030. The major drivers for this market are the increasing prevalence of cancer, preference for non-invasive procedures, and increasing need of early detection of high precision diseases in real time.

The liquid biopsy market has witnessed significant growth and is projected to continue expanding in the coming years. The market size is influenced by factors such as the increasing incidence of cancer, rising demand for non-invasive diagnostic techniques, and the growing adoption of personalized medicine.

A total of 163 figures / charts and 129 tables are provided in this 264-page report to help in your business decisions. Sample figures with some insights are shown below. Sample figures with some insights are shown below.
Liquid Biopsy Market by Product, Circulating Biomarker, Application, Clinical Application, and End Use

Emerging Trends in Liquid Biopsy Market

The liquid biopsy market has emerged as a disruptive technology in the field of oncology, offering numerous advantages over traditional tissue biopsies. It provides real-time and dynamic information about a patient's tumor profile, facilitating precision medicine approaches and personalized treatment decisions. Liquid biopsy has applications in various cancer types, including lung, breast, colorectal, prostate, and pancreatic cancer, among others. The market is driven by factors such as the increasing prevalence of cancer, the need for early and accurate diagnosis, and advancements in sequencing technologies.

Furthermore, the report includes a detailed market analysis of liquid biopsy technologies, such as ctDNA-based assays, CTC-based assays, and exosome-based assays. It examines the regulatory landscape and reimbursement policies affecting the liquid biopsy market, along with the impact of emerging technologies like next-generation sequencing (NGS), digital PCR, and microfluidics on liquid biopsy adoption and market growth.

Emerging trends, which have a direct impact on the dynamics of the industry, include the usage of methylation-specific polymerase chain reaction (MS-PCR) liquid biopsy technology and the emergence of hybrid ctDNA and CTC target selector.
Liquid Biopsy Market by Segments

Liquid Biopsy Market by Segment

The global liquid biopsy market is witnessing significant growth, driven by the need for early cancer detection, personalized medicine, and non-invasive diagnostic approaches. Market share is concentrated among key players, with ongoing investments in research and development to enhance liquid biopsy technologies and expand their applications. The market size is projected to grow substantially, fueled by increasing cancer incidence, advancements in sequencing technologies, and the growing adoption of precision medicine.

In this market, therapy selection is the largest clinical application market, and circulating tumor DNA is the largest circulating biomarker segment. Growth in various segments of the liquid biopsy market are shown in the figure below. The study includes trends and forecast for the global liquid biopsy market by product, circulating biomarker, application, clinical application, end use, and region as follows:

Liquid Biopsy Market by Product [Value ($M) from 2018 to 2030]:

Liquid Biopsy Market by Circulating Biomarker [Value ($M) from 2018 to 2030]:

Liquid Biopsy Market by Application [Value ($M) from 2018 to 2030]:

Liquid Biopsy Market by Clinical Application [Value ($M) from 2018 to 2030]:

  • Early Cancer Screening
  • Therapy Selection
  • Treatment Monitoring
  • Recurrence Monitoring

Liquid Biopsy Market by End Use [Value ($M) from 2018 to 2030]:

  • Reference Laboratories
  • Hospitals and Physician Laboratories
  • Academic and Research Centers
  • Other End Uses

Liquid Biopsy Market by Region [Value ($M) from 2018 to 2030]:

Liquid Biopsy Market Size and Share

The market share dynamics within the liquid biopsy market are evolving, with new entrants and specialized companies gaining traction in specific market segments. Collaboration and partnerships between diagnostic companies, research institutions, and pharmaceutical companies are driving technological advancements and expanding the clinical utility of liquid biopsy.

The liquid biopsy market holds immense potential for improving cancer care by enabling early detection, monitoring treatment response, and detecting minimal residual disease. As healthcare systems worldwide strive to enhance patient outcomes, reduce healthcare costs, and deliver targeted therapies, the adoption of liquid biopsy techniques is anticipated to accelerate.

List of Liquid Biopsy Companies

In terms of market share, the liquid biopsy market is dominated by key players such as Bio-Rad Laboratories, Guardant Health, MDxHealth and Qiagen. These companies have established themselves as leaders in the liquid biopsy industry, offering a range of liquid biopsy platforms, kits, and services. They invest heavily in research and development to drive innovation and meet the evolving needs of healthcare providers and patients.
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, liquid biopsy companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the liquid biopsy companies profiled in this report include-
  • Guardant
  • Bio-Rad Laboratories
  • Qiagen
  • MDxHealth
  • Myriad Genetics
  • Biocept
  • Roche
  • Illumina
  • Thermofisher

Liquid Biopsy Market Insights

  • Lucintel forecasts circulating tumor DNA will remain the largest segment and is also expected to witness the highest growth over the forecast period due to increasing use of ctDNA biomarkers in next-generation sequencing (NGS) technologies for detecting diseases in real time and in early stage.
  • Therapy selection will remain the largest clinical application over the forecast period due to its offerings of various benefits, such as non-invasiveness, access to tumor heterogeneity, real-time treatment monitoring, and recurrence detection in advance of significant tumor formation or metastasis.
  • APAC will remain the fastest growing region over the forecast period due to rising non-invasive treatment, a rising incidence of cancer, and improving healthcare infrastructure.

Features of the Global Liquid Biopsy Market

  • Market Size Estimates: Global liquid biopsy market size estimation in terms of value ($B) shipment.
  • Trend and Forecast Analysis: Market trends (2018-2023) and forecast (2024-2030) by various segments.
  • Segmentation Analysis: Global liquid biopsy market size by product, circulating biomarker, application, clinical application, end use, and region in terms of value.
  • Regional Analysis: Global liquid biopsy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different by product, circulating biomarker, application, clinical application, end use, and region for the global liquid biopsy market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global liquid biopsy market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model

Frequently Asked Questions (FAQ)

Q1. What is the market size of liquid biopsy?
Answer: The global liquid biopsy market is expected to reach an estimated $9.3 billion by 2030.
Q2. What is the growth forecast for the liquid biopsy market?
Answer: The global liquid biopsy market is expected to grow at a CAGR of 13.3% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the liquid biopsy market?
Answer: The major drivers for this market are increasing prevalence of cancer, preference for non-invasive procedures, and increasing need for early detection of high precision diseases in real time.
Q4. What is the current use of liquid biopsy?
Answer: Early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring are the major clinical application segments of liquid biopsy.
Q5. What are the emerging trends in the liquid biopsy market?
Answer: Emerging trends, which have a direct impact on the dynamics of the industry, include the usage of methylation-specific polymerase chain reaction (MS-PCR) liquid biopsy technology and the emergence of hybrid ctDNA and CTC target selector.
Q6. What are the top 5 liquid biopsy companies?
Answer: Some of the key liquid biopsy companies are as follows:
  • Guardant
  • Bio-Rad Laboratories
  • Qiagen
  • MDxHealth
  • Myriid Genetics
  • Biocept
  • Roche
  • Illumina
  • Thermofisher
Q7.Which will be the largest circulating biomarker segment of the liquid biopsy market in the future?
Answer: Lucintel forecasts that circulating tumor DNA (ctDNA) will remain the largest segment, and it is also expected to witness the highest growth over the forecast period due to increasing use of ctDNA biomarkers in next-generation sequencing (NGS) technologies for detecting diseases in real time and in the early stage.
Q8: In liquid biopsy market, which region is expected to be the largest in the next five years?
Answer: Asia Pacific is expected to be the largest region over the next five years.
Q9. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions

Q.1 What are some of the most promising growth opportunities for the global liquid biopsy market by product (assay kits, instruments, and services), circulating biomarker (circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other biomarkers), application (oncology and non-cancer liquid biopsies), clinical application (early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring), end use (reference laboratories, hospitals and physician laboratories, academic and research centers, and other end uses), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global liquid biopsy market?
Q.5 What are the business risks and threats to the global liquid biopsy market?
Q.6 What are the emerging trends in this liquid biopsy market and the reasons behind them?
Q.7 What are some changing demands of customers in the liquid biopsy market?
Q.8 What are the new developments in the liquid biopsy market? Which companies are leading these developments?
Q.9 Who are the major players in the liquid biopsy market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in the liquid biopsy market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global liquid biopsy market?
 
For any questions related to liquid biopsy market or related to Liquid biopsy market, liquid biopsy manufacture, liquid biopsy market, oncology diagnostic companies, biopsy market size, liquid biopsy market size, liquid biopsy market trends, liquid-based biopsy market research, oncology biopsy manufacturer, liquid biopsy market, liquid biopsy manufacturer, liquid biopsy market, liquid biospy market research, write Lucintel analyst at email: helpdesk@lucintel.com  we will be glad to get back to you soon.
Table of Contents
 
1. Executive Summary
 
2. Global Liquid Biopsy Market Background and Classifications
2.1: Introduction, Background and Classification
2.2: Supply Chain
2.3: Industry Drivers and Challenges
 
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1: Macroeconomic Trends and Forecasts
3.2: Global Liquid Biopsy Market Trends and Forecast
3.3: Global Liquid Biopsy Market by Product
3.3.1: Assay Kits
3.3.2: Instruments
3.3.3: Services
3.4: Global Liquid Biopsy Market by Circulating Biomarker
3.4.1: Circulating Tumor Cells (CTCs) 
3.4.2: Circulating Tumor DNA (ctDNA) 
3.4.3: Cell-Free DNA (cfDNA) 
3.4.4: Extracellular Vesicles (EVs) 
3.4.5: Other Circulating Biomarkers
3.5: Global Liquid Biopsy Market by Application
3.5.1: Oncology
3.5.1.1: Lung Cancer
3.5.1.2: Breast Cancer
3.5.1.3: Colorectal Cancer
3.5.1.4: Prostate Cancer
3.5.1.5: Liver Cancer
3.5.1.6: Other Cancer
3.5.2: Non-Cancer
3.6: Global Liquid Biopsy Market by Clinical Application
3.6.1: Early Cancer Screening
3.6.2: Therapy Selection
3.6.3: Treatment Monitoring
3.6.4: Recurrence Monitoring
3.7: Global Liquid Biopsy Market by End User
3.7.1: Reference Laboratories
3.7.2: Hospitals and Physician Laboratories
3.7.3: Academic and Research Centers
3.7.4: Other End Users
 
4. Market Trends and Forecast Analysis from 2018 to 2030
4.1: Global Liquid Biopsy Market by Region
4.2: North American Liquid Biopsy Market Trends and Forecast
4.2.1: North American Liquid Biopsy Market by Product
4.2.2: North American Liquid Biopsy Market by Circulating Biomarker
4.2.3: North American Liquid Biopsy Market by Application
4.2.4: North American Liquid Biopsy Market by Clinical Application
4.2.5: North American Liquid Biopsy Market by End Use
4.2.6: United States Liquid Biopsy Market
4.2.7: Canadian Liquid Biopsy Market
4.2.8: Mexican Liquid Biopsy Market
4.3: European Liquid Biopsy Market Trends and Forecast
4.3.1: European Liquid Biopsy Market by Product
4.3.2: European Liquid Biopsy Market by Circulating Biomarker
4.3.3: European Liquid Biopsy Market by Application
4.3.4: European Liquid Biopsy Market by Clinical Application
4.3.5: European Liquid Biopsy Market by End Use
4.3.6: United Kingdom Liquid Biopsy Market
4.3.7: German Liquid Biopsy Market
4.3.8: French Liquid Biopsy Market
4.3.9: Italian Liquid Biopsy Market
4.3.10: Spanish Liquid Biopsy Market
4.4: APAC Liquid Biopsy Market Trends and Forecast
4.4.1: APAC Liquid Biopsy Market by Product
4.4.2: APAC Liquid Biopsy Market by Circulating Biomarker
4.4.3: APAC Liquid Biopsy Market by Application
4.4.4: APAC Liquid Biopsy Market by Clinical Application
4.4.5: APAC Liquid Biopsy Market by End Use
4.4.6: Japanese Liquid Biopsy Market
4.4.7: Chinese Liquid Biopsy Market
4.4.8: Indian Liquid Biopsy Market
4.5: ROW Liquid Biopsy Market Trends and Forecast
4.5.1: ROW Liquid Biopsy Market by Product
4.5.2: ROW Liquid Biopsy Market by Circulating Biomarker
4.5.3: ROW Liquid Biopsy Market by Application
4.5.4: ROW Liquid Biopsy Market by Clinical Application
4.5.5: ROW Liquid Biopsy Market by End Use
4.5.6: Brazilian Liquid Biopsy Market
 
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Market Share Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
 
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Liquid Biopsy Market by Product
6.1.2: Growth Opportunities for the Global Liquid Biopsy Market by Circulating Biomarker
6.1.3: Growth Opportunities for the Global Liquid Biopsy Market by Application
6.1.4: Growth Opportunities for the Global Liquid Biopsy Market by Clinical Application
6.1.5: Growth Opportunities for the Global Liquid Biopsy Market by End Use
6.1.6: Growth Opportunities for the Global Liquid Biopsy Market by Region
6.2: Emerging Trends in the Global Liquid Biopsy Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Licensing and Certification
6.3.3: Mergers, Acquisitions, Joint Ventures, and Other Collaborations in the Global Liquid Biopsy Market
 
7. Company Profiles of Leading Players
7.1: Bio-Rad Laboratories
7.2: QIAGEN
7.3: MDxHealth
7.4: Myriad Genetics
7.5: Biocept, Inc. 
7.6: F. Hoffmann-La Roche Ltd. 
7.7: Thermo Fisher Scientific Inc. 
7.8: Illumina, Inc. 
7.9: Cardiff Oncology
7.10: Guardant Health
 
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Liquid Biopsy Market: Trends, Opportunities and Competitive Analysis to 2030 Full Report $ 4,850
164 figures/charts and 129 tables are provided in this 264 - page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process. 
 

Please sign in below to get report brochure - Liquid Biopsy Market.

At Lucintel, we respect your privacy and maintain the confidentiality of information / data provided by you
(Please enter your corporate email. * These fields are mandatory )
Have an Account / Returning Visitors?